Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxcarbazepine Monotherapy in Adult Partial Seizures
NCT00275925Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxcarbazepine in focal seizures, sponsored by Novartis. Primary endpoints: Epileptic activity at electroencephalography in rest, Flash light and hyperventilation test with electroencephalography and 3 more. Started Dec 2005; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00275925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275925.